Relationship between particle size and lung retention time of intact solid lipid nanoparticle suspensions after pulmonary delivery.
Lung retention time
Nanocarriers
Particle size
Pulmonary delivery
Solid lipid nanoparticle suspensions
Journal
Journal of controlled release : official journal of the Controlled Release Society
ISSN: 1873-4995
Titre abrégé: J Control Release
Pays: Netherlands
ID NLM: 8607908
Informations de publication
Date de publication:
10 09 2020
10 09 2020
Historique:
received:
14
12
2019
revised:
02
06
2020
accepted:
04
06
2020
pubmed:
4
7
2020
medline:
22
6
2021
entrez:
4
7
2020
Statut:
ppublish
Résumé
The relationship between the particle size and lung retention time of inhaled nanocarriers was unclear, and this uncertainty hampered the design of nanocarriers for pulmonary delivery. The debate resulted from a lack of knowledge regarding the integrity of the involved nanocarriers. A distinguishable bioimaging probe which could differentiate between integrated and disintegrated nanocarriers by emitting different signals was introduced to address this problem. The aza-BODIPY structured aggregation-caused quenching (ACQ) probes were promising candidates, because they showed intense fluorescence signals in intact nanocarriers while quenched after the decomposition of nanocarriers. This attribute was called an on-off switch. In this paper, ACQ probes were encapsulated into a solid lipid nanoparticle suspension (SLNS) with different particle sizes (120-480 nm), and the relationship between particle size and lung retention time after pulmonary delivery was investigated in BALB/c mice. The results showed that a larger particle size led to a longer lung retention time. By comparing with the results of a non-water-quenching probe, the SLNS systems were found to be mostly intact in the pulmonary region. These findings will serve as a firm basis for the design and development of nanocarriers for pulmonary delivery.
Identifiants
pubmed: 32619747
pii: S0168-3659(20)30336-9
doi: 10.1016/j.jconrel.2020.06.004
pii:
doi:
Substances chimiques
Drug Carriers
0
Lipids
0
Suspensions
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
206-222Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that there are no competing financial interests regarding this study.